FOLFIRI.3, a new regimen combining 5-fluorouracil, folinic acid and irinotecan, for advanced pancreatic cancer: results of an Association des Gastro-Entérologues Oncologues (Gastroenterologist Oncologist Association) multicenter phase II study
Titel:
FOLFIRI.3, a new regimen combining 5-fluorouracil, folinic acid and irinotecan, for advanced pancreatic cancer: results of an Association des Gastro-Entérologues Oncologues (Gastroenterologist Oncologist Association) multicenter phase II study
Auteur:
Taïeb, J. Lecomte, T. Aparicio, T. Asnacios, A. Mansourbakht, T. Artru, P. Fallik, D. Spano, J.P. Landi, B. Lledo, G. Desrame, J.